Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease

Neurobiology of Aging
Marianna ZanaJános Kálmán

Abstract

Besides the genetic, biochemical and neuropathological analogies between Down's syndrome (DS) and Alzheimer's disease (AD), there is ample evidence of the involvement of oxidative stress (OS) in the pathogenesis of both disorders. The present paper reviews the publications on DS and AD in the past 10 years in light of the "gene dosage" and "two-hit" hypotheses, with regard to the alterations caused by OS in both the central nervous system and the periphery, and the main pipeline of antioxidant therapeutic strategies. OS occurs decades prior to the signature pathology and manifests as lipid, protein and DNA oxidation, and mitochondrial abnormalities. In clinical settings, the assessment of OS has traditionally been hampered by the use of assays that suffer from inherent problems related to specificity and/or sensitivity, which explains some of the conflicting results presented in this work. For DS, no scientifically proven diet or drug is yet available, and AD trials have not provided a satisfactory approach for the prevention of and therapy against OS, although most of them still need evidence-based confirmation. In the future, a balanced up-regulation of endogenous antioxidants, together with multiple exogenous antioxidant sup...Continue Reading

References

Aug 28, 1992·Science·E R Stadtman
Nov 21, 1992·Annals of the New York Academy of Sciences·C D SmithW R Markesbery
Sep 1, 1992·Mutation Research·M Dizdaroglu
Aug 1, 1992·Journal of Intellectual Disability Research : JIDR·S M PueschelJ E Haddow
Dec 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·C D SmithW R Markesbery
Jan 1, 1991·Gerontology·M I MelaragnoJ T Toniolo Neto
Jul 1, 1991·Journal of Geriatric Psychiatry and Neurology·L S SchneiderR B Sloane
Jan 31, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·N KurobeK Kato
Jan 1, 1990·Advances in Experimental Medicine and Biology·E AntilaT Westermarck
Mar 1, 1988·Mutation Research·P GadhiaH Zankl
Aug 1, 1989·Clinical Genetics·N CrostiA Serra
Aug 1, 1989·Developmental Medicine and Child Neurology·R T BidderM Hughes
Dec 1, 1989·Ophthalmic Paediatrics and Genetics·A BrásJ Rueff
Jan 15, 1988·Clinica Chimica Acta; International Journal of Clinical Chemistry·T PorstmannR von Baehr
Jul 1, 1986·Neurobiology of Aging·J H GrowdonT J Rosen
Dec 1, 1982·Mutation Research·J C Leonard, T Merz
Nov 13, 1995·Biochemical and Biophysical Research Communications·C BehlF Holsboer
Apr 12, 1995·JAMA : the Journal of the American Medical Association·M W GillmanP A Wolf
Mar 23, 1995·Nature·M A SmithG Perry
Jan 1, 1994·Methods in Enzymology·A Z Reznick, L Packer
Aug 2, 1994·Proceedings of the National Academy of Sciences of the United States of America·S D YanM A Smith
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·M P VitekA Cerami

❮ Previous
Next ❯

Citations

May 27, 2009·Biological Trace Element Research·Adriana S LimaSilvia F Cozzolino
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Jason P WeickAnita Bhattacharyya
Dec 29, 2011·Current Gerontology and Geriatrics Research·Marzia Perluigi, D Allan Butterfield
Sep 15, 2010·BMC Medical Genomics·Valerio CostaClaudio Napoli
May 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Donna K SlonimDiana W Bianchi
Nov 30, 2013·International Journal of Alzheimer's Disease·Nathalie ArnalCarlos A Marra
Dec 17, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·G DogliottiM M Corsi
Nov 14, 2016·Free Radical Biology & Medicine·Eugenio BaroneMarzia Perluigi
Sep 14, 2014·Current Neurology and Neuroscience Reports·John M RingmanUNKNOWN Dominantly Inherited Alzheimer Network
Oct 3, 2012·Proteomics. Clinical Applications·Jeriel T R KeeneyD Allan Butterfield
Nov 22, 2013·Proteomics. Clinical Applications·Marzia PerluigiD Allan Buttterfield
Aug 4, 2009·Journal of Neurochemistry·Keiichi IshiharaKazuhiro Yamakawa
Mar 5, 2019·Developmental Neurobiology·E Zamponi, P R Helguera
Aug 9, 2011·Expert Review of Proteomics·Marzia Perluigi, D Allan Butterfield
Nov 9, 2017·Oncotarget·Xiangbing MaoJun He
Mar 2, 2011·Proteomics. Clinical Applications·Marzia PerluigiRaffaella Coccia
Feb 2, 2017·Frontiers in Aging Neuroscience·Ni-Chung LeeMing-Jang Chiu
Sep 15, 2016·Antioxidants & Redox Signaling·Antonella TramutolaMarzia Perluigi
Jan 30, 2019·Oxidative Medicine and Cellular Longevity·Nicola LaforgiaNicoletta Resta
Jul 25, 2017·Neurology and Therapy·Ni-Chung LeeWuh-Liang Hwu
Jan 16, 2019·International Journal of Molecular Sciences·Teresa JanasTadeusz Janas
Dec 4, 2019·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Keiichi IshiharaSatoshi Akiba
Aug 8, 2019·Developmental Neurobiology·Melissa E Petersen, Sid E O'Bryant
Mar 7, 2021·Biomolecules·Chiara Lanzillotta, Fabio Di Domenico
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Marta Ferrari, Stefano Stagi
Nov 6, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andre StrydomZuzana Walker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.